Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 1:12 AM
NCT ID:
NCT02098993
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ACS defined as a new pulmonary infiltrate involving at least one segment of the lung on a chest x-ray or chest CT scan with 2 or more of the following: chest pain, tachypnea, dyspnea, cough, hypoxemia, or body temperature greater than or equal to 38.0 degrees Celsius
* Hemoglobin electrophoresis confirming HbSS, SC, or B0 (historical records sufficient)
* Age greater than or equal to 18
Exclusion Criteria:
* Any absolute contraindication to heparin
* Platelet count less than 50 per microliter (current admission)
* Historical diagnosis of moyamoya disease as documented in medical records
* Historical diagnosis of proliferative retinopathy as documented in medical records
* Current participation in a chronic exchange transfusion program
* Underlying hypercoagulable disorder other than sickle cell disease
* Currently receiving therappeutic anticoagulation
* Currently receiving antiplatelet agents
* Currently receiving estrogen containing oral contraceptives
* Chest CT scan documented PE performed as standard of care prior to study enrollment (current admission)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02098993
Study Brief:
Protocol Section:
NCT02098993